- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Is There a Role for FAPI PET in Urological Cancers? ; volume:28 ; number:6 ; day:24 ; month:8 ; year:2024 ; pages:721-725 ; date:11.2024
Molecular diagnosis & therapy ; 28, Heft 6 (24.8.2024), 721-725, 11.2024
- Creator
-
Ortolan, Naima
Urso, Luca
Zamberlan, Ilaria
Filippi, Luca
Buffi, Nicolò Maria
Cittanti, Corrado
Uccelli, Licia
Bartolomei, Mirco
Evangelista, Laura
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40291-024-00735-9
- URN
-
urn:nbn:de:101:1-2501162106090.148294165595
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ortolan, Naima
- Urso, Luca
- Zamberlan, Ilaria
- Filippi, Luca
- Buffi, Nicolò Maria
- Cittanti, Corrado
- Uccelli, Licia
- Bartolomei, Mirco
- Evangelista, Laura
- SpringerLink (Online service)
Other Objects (12)
FAPI-PET in cardiovascular disease
Comparative analysis of two timepoints on [18F]FAPI-42 PET/CT in various cancers
Melatonin and urological cancers: a new therapeutic approach
Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers
Prognostic factors in urological cancers : proceedings of the 1st International Symposium on Prognostic Factors in Urological Cancers, Munich, Germany 1992 ; 63 tables
Emerging photodynamic/sonodynamic therapies for urological cancers: progress and challenges
Correction to: Melatonin and urological cancers: a new therapeutic approach
Wnt signaling pathways in urological cancers: past decades and still growing
Supportive care interventions for men with urological cancers: a scoping review
68Ga-FAPI-PET/CT in patients with various gynecological malignancies
The role of RNA modification in urological cancers: mechanisms and clinical potential
68Ga- or 18F-FAPI PET/CT—what it can and cannot
FAPI-PET in cardiovascular disease
Comparative analysis of two timepoints on [18F]FAPI-42 PET/CT in various cancers
Melatonin and urological cancers: a new therapeutic approach
Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers
Prognostic factors in urological cancers : proceedings of the 1st International Symposium on Prognostic Factors in Urological Cancers, Munich, Germany 1992 ; 63 tables
Emerging photodynamic/sonodynamic therapies for urological cancers: progress and challenges
Correction to: Melatonin and urological cancers: a new therapeutic approach
Wnt signaling pathways in urological cancers: past decades and still growing
Supportive care interventions for men with urological cancers: a scoping review
68Ga-FAPI-PET/CT in patients with various gynecological malignancies
The role of RNA modification in urological cancers: mechanisms and clinical potential
68Ga- or 18F-FAPI PET/CT—what it can and cannot
FAPI-PET in cardiovascular disease
Comparative analysis of two timepoints on [18F]FAPI-42 PET/CT in various cancers
Melatonin and urological cancers: a new therapeutic approach
Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers
Prognostic factors in urological cancers : proceedings of the 1st International Symposium on Prognostic Factors in Urological Cancers, Munich, Germany 1992 ; 63 tables
Emerging photodynamic/sonodynamic therapies for urological cancers: progress and challenges
Correction to: Melatonin and urological cancers: a new therapeutic approach
Wnt signaling pathways in urological cancers: past decades and still growing
Supportive care interventions for men with urological cancers: a scoping review
68Ga-FAPI-PET/CT in patients with various gynecological malignancies
The role of RNA modification in urological cancers: mechanisms and clinical potential